Non-alcoholic Steatohepatitis Treatment Market Size, Share & Trends Report

Non-alcoholic Steatohepatitis Treatment Market Size, Share & Trends Analysis Report By Drug (Vitamin E & Pioglitazone, Resmetirom), By Disease Stage, By Distribution Channel, By Region, And Segment Forecasts, 2025 - 2030

Report ID: GVR-4-68039-964-6
Number of Report Pages: 110
Format: PDF, Horizon Databook

Historical Range: 2018 - 2024
Forecast Period: 2025 - 2030
Industry: Healthcare

Market Segmentation

Non-Alcoholic Steatohepatitis (NASH) Treatment Drug Outlook (Revenue, USD Million, 2018 - 2030)
- Vitamin E and Pioglitazone
- Obeticholic Acid (OCA)
- Lanifibranor
- Semaglutide
- Resmetirom
- Aramchol
- Cenicriviroc
- Other Drugs
Non-Alcoholic Steatohepatitis (NASH) Treatment Disease Stage Outlook (Revenue, USD Million, 2018 - 2030)
- NASH Stage F0
- NASH Stage F1
- NASH Stage F2
- NASH Stage F3
- NASH Stage F4
Non-Alcoholic Steatohepatitis (NASH) Treatment Distribution Channel Outlook (Revenue, USD Million, 2018 - 2030)
- Hospital Pharmacies
- Retail and Specialty Pharmacies
- Other Pharmacies
Non-Alcoholic Steatohepatitis (NASH) Treatment Regional Outlook (Revenue, USD Million, 2018 - 2030)
- North America
  - North America Non-Alcoholic Steatohepatitis (NASH) Treatment Market, By Drug
    - Vitamin E and Pioglitazone
    - Obeticholic Acid (OCA)
    - Lanifibranor
    - Semaglutide
    - Resmetirom
    - Aramchol
    - Cenicriviroc
    - Other Drugs
    - Total
  - North America Non-Alcoholic Steatohepatitis (NASH) Treatment Market, By Disease Stage
    - NASH Stage F0
    - NASH Stage F1
    - NASH Stage F2
    - NASH Stage F3
    - NASH Stage F4
  - North America Non-Alcoholic Steatohepatitis (NASH) Treatment Market, By Distribution Channel
    - Hospital Pharmacies
    - Retail and Specialty Pharmacies
    - Other Pharmacies
  - U.S.
    - U.S. Non-Alcoholic Steatohepatitis (NASH) Treatment Market, By Drug
      - Vitamin E and Pioglitazone
      - Obeticholic Acid (OCA)
      - Lanifibranor
      - Semaglutide
      - Resmetirom
      - Aramchol
      - Cenicriviroc
      - Other Drugs
      - Total
    - U.S. Non-Alcoholic Steatohepatitis (NASH) Treatment Market, By Disease Stage
      - NASH Stage F0
      - NASH Stage F1
      - NASH Stage F2
      - NASH Stage F3
      - NASH Stage F4
    - U.S. Non-Alcoholic Steatohepatitis (NASH) Treatment Market, By Distribution Channel
      - Hospital Pharmacies
      - Retail and Specialty Pharmacies
      - Other Pharmacies
  - Canada
    - Canada Non-Alcoholic Steatohepatitis (NASH) Treatment Market, By Drug
      - Vitamin E and Pioglitazone
      - Obeticholic Acid (OCA)
      - Lanifibranor
      - Semaglutide
      - Resmetirom
      - Aramchol
      - Cenicriviroc
      - Other Drugs
      - Total
    - Canada Non-Alcoholic Steatohepatitis (NASH) Treatment Market, By Disease Stage
      - NASH Stage F0
      - NASH Stage F1
      - NASH Stage F2
      - NASH Stage F3
      - NASH Stage F4
    - Canada Non-Alcoholic Steatohepatitis (NASH) Treatment Market, By Distribution Channel
      - Hospital Pharmacies
      - Retail and Specialty Pharmacies
      - Other Pharmacies
  - Mexico
    - Mexico Non-Alcoholic Steatohepatitis (NASH) Treatment Market, By Drug
      - Vitamin E and Pioglitazone
      - Obeticholic Acid (OCA)
      - Lanifibranor
      - Semaglutide
      - Resmetirom
      - Aramchol
      - Cenicriviroc
      - Other Drugs
      - Total
    - Mexico Non-Alcoholic Steatohepatitis (NASH) Treatment Market, By Disease Stage
      - NASH Stage F0
      - NASH Stage F1
      - NASH Stage F2
      - NASH Stage F3
      - NASH Stage F4
    - Mexico Non-Alcoholic Steatohepatitis (NASH) Treatment Market, By Distribution Channel
      - Hospital Pharmacies
      - Retail and Specialty Pharmacies
      - Other Pharmacies
- Europe
  - Europe Non-Alcoholic Steatohepatitis (NASH) Treatment Market, By Drug
    - Vitamin E and Pioglitazone
    - Obeticholic Acid (OCA)
    - Lanifibranor
    - Semaglutide
    - Resmetirom
    - Aramchol
    - Cenicriviroc
    - Other Drugs
    - Total
  - Europe Non-Alcoholic Steatohepatitis (NASH) Treatment Market, By Disease Stage
    - NASH Stage F0
    - NASH Stage F1
    - NASH Stage F2
    - NASH Stage F3
    - NASH Stage F4
  - Europe Non-Alcoholic Steatohepatitis (NASH) Treatment Market, By Distribution Channel
    - Hospital Pharmacies
    - Retail and Specialty Pharmacies
    - Other Pharmacies
  - Germany
    - Germany Non-Alcoholic Steatohepatitis (NASH) Treatment Market, By Drug
      - Vitamin E and Pioglitazone
      - Obeticholic Acid (OCA)
      - Lanifibranor
      - Semaglutide
      - Resmetirom
      - Aramchol
      - Cenicriviroc
      - Other Drugs
      - Total
    - Germany Non-Alcoholic Steatohepatitis (NASH) Treatment Market, By Disease Stage
      - NASH Stage F0
      - NASH Stage F1
      - NASH Stage F2
      - NASH Stage F3
      - NASH Stage F4
    - Germany Non-Alcoholic Steatohepatitis (NASH) Treatment Market, By Distribution Channel
      - Hospital Pharmacies
      - Retail and Specialty Pharmacies
      - Other Pharmacies
  - UK
    - UK Non-Alcoholic Steatohepatitis (NASH) Treatment Market, By Drug
      - Vitamin E and Pioglitazone
      - Obeticholic Acid (OCA)
      - Lanifibranor
      - Semaglutide
      - Resmetirom
      - Aramchol
      - Cenicriviroc
      - Other Drugs
      - Total
    - UK Non-Alcoholic Steatohepatitis (NASH) Treatment Market, By Disease Stage
      - NASH Stage F0
      - NASH Stage F1
      - NASH Stage F2
      - NASH Stage F3
      - NASH Stage F4
    - UK Non-Alcoholic Steatohepatitis (NASH) Treatment Market, By Distribution Channel
      - Hospital Pharmacies
      - Retail and Specialty Pharmacies
      - Other Pharmacies
  - France
    - France Non-Alcoholic Steatohepatitis (NASH) Treatment Market, By Drug
      - Vitamin E and Pioglitazone
      - Obeticholic Acid (OCA)
      - Lanifibranor
      - Semaglutide
      - Resmetirom
      - Aramchol
      - Cenicriviroc
      - Other Drugs
      - Total
    - France Non-Alcoholic Steatohepatitis (NASH) Treatment Market, By Disease Stage
      - NASH Stage F0
      - NASH Stage F1
      - NASH Stage F2
      - NASH Stage F3
      - NASH Stage F4
    - France Non-Alcoholic Steatohepatitis (NASH) Treatment Market, By Distribution Channel
      - Hospital Pharmacies
      - Retail and Specialty Pharmacies
      - Other Pharmacies
  - Italy
    - Italy Non-Alcoholic Steatohepatitis (NASH) Treatment Market, By Drug
      - Vitamin E and Pioglitazone
      - Obeticholic Acid (OCA)
      - Lanifibranor
      - Semaglutide
      - Resmetirom
      - Aramchol
      - Cenicriviroc
      - Other Drugs
      - Total
    - Italy Non-Alcoholic Steatohepatitis (NASH) Treatment Market, By Disease Stage
      - NASH Stage F0
      - NASH Stage F1
      - NASH Stage F2
      - NASH Stage F3
      - NASH Stage F4
    - Italy Non-Alcoholic Steatohepatitis (NASH) Treatment Market, By Distribution Channel
      - Hospital Pharmacies
      - Retail and Specialty Pharmacies
      - Other Pharmacies
  - Spain
    - Spain Non-Alcoholic Steatohepatitis (NASH) Treatment Market, By Drug
      - Vitamin E and Pioglitazone
      - Obeticholic Acid (OCA)
      - Lanifibranor
      - Semaglutide
      - Resmetirom
      - Aramchol
      - Cenicriviroc
      - Other Drugs
      - Total
    - Spain Non-Alcoholic Steatohepatitis (NASH) Treatment Market, By Disease Stage
      - NASH Stage F0
      - NASH Stage F1
      - NASH Stage F2
      - NASH Stage F3
      - NASH Stage F4
    - Spain Non-Alcoholic Steatohepatitis (NASH) Treatment Market, By Distribution Channel
      - Hospital Pharmacies
      - Retail and Specialty Pharmacies
      - Other Pharmacies
  - Denmark
    - Denmark Non-Alcoholic Steatohepatitis (NASH) Treatment Market, By Drug
      - Vitamin E and Pioglitazone
      - Obeticholic Acid (OCA)
      - Lanifibranor
      - Semaglutide
      - Resmetirom
      - Aramchol
      - Cenicriviroc
      - Other Drugs
      - Total
    - Denmark Non-Alcoholic Steatohepatitis (NASH) Treatment Market, By Disease Stage
      - NASH Stage F0
      - NASH Stage F1
      - NASH Stage F2
      - NASH Stage F3
      - NASH Stage F4
    - Denmark Non-Alcoholic Steatohepatitis (NASH) Treatment Market, By Distribution Channel
      - Hospital Pharmacies
      - Retail and Specialty Pharmacies
      - Other Pharmacies
  - Sweden
    - Sweden Non-Alcoholic Steatohepatitis (NASH) Treatment Market, By Drug
      - Vitamin E and Pioglitazone
      - Obeticholic Acid (OCA)
      - Lanifibranor
      - Semaglutide
      - Resmetirom
      - Aramchol
      - Cenicriviroc
      - Other Drugs
      - Total
    - Sweden Non-Alcoholic Steatohepatitis (NASH) Treatment Market, By Disease Stage
      - NASH Stage F0
      - NASH Stage F1
      - NASH Stage F2
      - NASH Stage F3
      - NASH Stage F4
    - Sweden Non-Alcoholic Steatohepatitis (NASH) Treatment Market, By Distribution Channel
      - Hospital Pharmacies
      - Retail and Specialty Pharmacies
      - Other Pharmacies
  - Norway
    - Norway Non-Alcoholic Steatohepatitis (NASH) Treatment Market, By Drug
      - Vitamin E and Pioglitazone
      - Obeticholic Acid (OCA)
      - Lanifibranor
      - Semaglutide
      - Resmetirom
      - Aramchol
      - Cenicriviroc
      - Other Drugs
      - Total
    - Norway Non-Alcoholic Steatohepatitis (NASH) Treatment Market, By Disease Stage
      - NASH Stage F0
      - NASH Stage F1
      - NASH Stage F2
      - NASH Stage F3
      - NASH Stage F4
    - Norway Non-Alcoholic Steatohepatitis (NASH) Treatment Market, By Distribution Channel
      - Hospital Pharmacies
      - Retail and Specialty Pharmacies
      - Other Pharmacies
- Asia Pacific
  - Asia Pacific Non-Alcoholic Steatohepatitis (NASH) Treatment Market, By Drug
    - Vitamin E and Pioglitazone
    - Obeticholic Acid (OCA)
    - Lanifibranor
    - Semaglutide
    - Resmetirom
    - Aramchol
    - Cenicriviroc
    - Other Drugs
    - Total
  - Asia Pacific Non-Alcoholic Steatohepatitis (NASH) Treatment Market, By Disease Stage
    - NASH Stage F0
    - NASH Stage F1
    - NASH Stage F2
    - NASH Stage F3
    - NASH Stage F4
  - Asia Pacific Non-Alcoholic Steatohepatitis (NASH) Treatment Market, By Distribution Channel
    - Hospital Pharmacies
    - Retail and Specialty Pharmacies
    - Other Pharmacies
  - China
    - China Non-Alcoholic Steatohepatitis (NASH) Treatment Market, By Drug
      - Vitamin E and Pioglitazone
      - Obeticholic Acid (OCA)
      - Lanifibranor
      - Semaglutide
      - Resmetirom
      - Aramchol
      - Cenicriviroc
      - Other Drugs
      - Total
    - China Non-Alcoholic Steatohepatitis (NASH) Treatment Market, By Disease Stage
      - NASH Stage F0
      - NASH Stage F1
      - NASH Stage F2
      - NASH Stage F3
      - NASH Stage F4
    - China Non-Alcoholic Steatohepatitis (NASH) Treatment Market, By Distribution Channel
      - Hospital Pharmacies
      - Retail and Specialty Pharmacies
      - Other Pharmacies
  - Japan
    - Japan Non-Alcoholic Steatohepatitis (NASH) Treatment Market, By Drug
      - Vitamin E and Pioglitazone
      - Obeticholic Acid (OCA)
      - Lanifibranor
      - Semaglutide
      - Resmetirom
      - Aramchol
      - Cenicriviroc
      - Other Drugs
      - Total
    - Japan Non-Alcoholic Steatohepatitis (NASH) Treatment Market, By Disease Stage
      - NASH Stage F0
      - NASH Stage F1
      - NASH Stage F2
      - NASH Stage F3
      - NASH Stage F4
    - Japan Non-Alcoholic Steatohepatitis (NASH) Treatment Market, By Distribution Channel
      - Hospital Pharmacies
      - Retail and Specialty Pharmacies
      - Other Pharmacies
  - India
    - India Non-Alcoholic Steatohepatitis (NASH) Treatment Market, By Drug
      - Vitamin E and Pioglitazone
      - Obeticholic Acid (OCA)
      - Lanifibranor
      - Semaglutide
      - Resmetirom
      - Aramchol
      - Cenicriviroc
      - Other Drugs
      - Total
    - India Non-Alcoholic Steatohepatitis (NASH) Treatment Market, By Disease Stage
      - NASH Stage F0
      - NASH Stage F1
      - NASH Stage F2
      - NASH Stage F3
      - NASH Stage F4
    - India Non-Alcoholic Steatohepatitis (NASH) Treatment Market, By Distribution Channel
      - Hospital Pharmacies
      - Retail and Specialty Pharmacies
      - Other Pharmacies
  - South Korea
    - South Korea Non-Alcoholic Steatohepatitis (NASH) Treatment Market, By Drug
      - Vitamin E and Pioglitazone
      - Obeticholic Acid (OCA)
      - Lanifibranor
      - Semaglutide
      - Resmetirom
      - Aramchol
      - Cenicriviroc
      - Other Drugs
      - Total
    - South Korea Non-Alcoholic Steatohepatitis (NASH) Treatment Market, By Disease Stage
      - NASH Stage F0
      - NASH Stage F1
      - NASH Stage F2
      - NASH Stage F3
      - NASH Stage F4
    - South Korea Non-Alcoholic Steatohepatitis (NASH) Treatment Market, By Distribution Channel
      - Hospital Pharmacies
      - Retail and Specialty Pharmacies
      - Other Pharmacies
  - Australia
    - Australia Non-Alcoholic Steatohepatitis (NASH) Treatment Market, By Drug
      - Vitamin E and Pioglitazone
      - Obeticholic Acid (OCA)
      - Lanifibranor
      - Semaglutide
      - Resmetirom
      - Aramchol
      - Cenicriviroc
      - Other Drugs
      - Total
    - Australia Non-Alcoholic Steatohepatitis (NASH) Treatment Market, By Disease Stage
      - NASH Stage F0
      - NASH Stage F1
      - NASH Stage F2
      - NASH Stage F3
      - NASH Stage F4
    - Australia Non-Alcoholic Steatohepatitis (NASH) Treatment Market, By Distribution Channel
      - Hospital Pharmacies
      - Retail and Specialty Pharmacies
      - Other Pharmacies
  - Thailand
    - Thailand Non-Alcoholic Steatohepatitis (NASH) Treatment Market, By Drug
      - Vitamin E and Pioglitazone
      - Obeticholic Acid (OCA)
      - Lanifibranor
      - Semaglutide
      - Resmetirom
      - Aramchol
      - Cenicriviroc
      - Other Drugs
      - Total
    - Thailand Non-Alcoholic Steatohepatitis (NASH) Treatment Market, By Disease Stage
      - NASH Stage F0
      - NASH Stage F1
      - NASH Stage F2
      - NASH Stage F3
      - NASH Stage F4
    - Thailand Non-Alcoholic Steatohepatitis (NASH) Treatment Market, By Distribution Channel
      - Hospital Pharmacies
      - Retail and Specialty Pharmacies
      - Other Pharmacies
- Latin America
  - Latin America Non-Alcoholic Steatohepatitis (NASH) Treatment Market, By Drug
    - Vitamin E and Pioglitazone
    - Obeticholic Acid (OCA)
    - Lanifibranor
    - Semaglutide
    - Resmetirom
    - Aramchol
    - Cenicriviroc
    - Other Drugs
    - Total
  - Latin America Non-Alcoholic Steatohepatitis (NASH) Treatment Market, By Disease Stage
    - NASH Stage F0
    - NASH Stage F1
    - NASH Stage F2
    - NASH Stage F3
    - NASH Stage F4
  - Latin America Non-Alcoholic Steatohepatitis (NASH) Treatment Market, By Distribution Channel
    - Hospital Pharmacies
    - Retail and Specialty Pharmacies
    - Other Pharmacies
  - Brazil
    - Brazil Non-Alcoholic Steatohepatitis (NASH) Treatment Market, By Drug
      - Vitamin E and Pioglitazone
      - Obeticholic Acid (OCA)
      - Lanifibranor
      - Semaglutide
      - Resmetirom
      - Aramchol
      - Cenicriviroc
      - Other Drugs
      - Total
    - Brazil Non-Alcoholic Steatohepatitis (NASH) Treatment Market, By Disease Stage
      - NASH Stage F0
      - NASH Stage F1
      - NASH Stage F2
      - NASH Stage F3
      - NASH Stage F4
    - Brazil Non-Alcoholic Steatohepatitis (NASH) Treatment Market, By Distribution Channel
      - Hospital Pharmacies
      - Retail and Specialty Pharmacies
      - Other Pharmacies
  - Argentina
    - Argentina Non-Alcoholic Steatohepatitis (NASH) Treatment Market, By Drug
      - Vitamin E and Pioglitazone
      - Obeticholic Acid (OCA)
      - Lanifibranor
      - Semaglutide
      - Resmetirom
      - Aramchol
      - Cenicriviroc
      - Other Drugs
      - Total
    - Argentina Non-Alcoholic Steatohepatitis (NASH) Treatment Market, By Disease Stage
      - NASH Stage F0
      - NASH Stage F1
      - NASH Stage F2
      - NASH Stage F3
      - NASH Stage F4
    - Argentina Non-Alcoholic Steatohepatitis (NASH) Treatment Market, By Distribution Channel
      - Hospital Pharmacies
      - Retail and Specialty Pharmacies
      - Other Pharmacies
- Middle East and Africa (MEA)
  - MEA Non-Alcoholic Steatohepatitis (NASH) Treatment Market, By Drug
    - Vitamin E and Pioglitazone
    - Obeticholic Acid (OCA)
    - Lanifibranor
    - Semaglutide
    - Resmetirom
    - Aramchol
    - Cenicriviroc
    - Other Drugs
    - Total
  - MEA Non-Alcoholic Steatohepatitis (NASH) Treatment Market, By Disease Stage
    - NASH Stage F0
    - NASH Stage F1
    - NASH Stage F2
    - NASH Stage F3
    - NASH Stage F4
  - MEA Non-Alcoholic Steatohepatitis (NASH) Treatment Market, By Distribution Channel
    - Hospital Pharmacies
    - Retail and Specialty Pharmacies
    - Other Pharmacies
  - South Africa
    - South Africa Non-Alcoholic Steatohepatitis (NASH) Treatment Market, By Drug
      - Vitamin E and Pioglitazone
      - Obeticholic Acid (OCA)
      - Lanifibranor
      - Semaglutide
      - Resmetirom
      - Aramchol
      - Cenicriviroc
      - Other Drugs
      - Total
    - South Africa Non-Alcoholic Steatohepatitis (NASH) Treatment Market, By Disease Stage
      - NASH Stage F0
      - NASH Stage F1
      - NASH Stage F2
      - NASH Stage F3
      - NASH Stage F4
    - South Africa Non-Alcoholic Steatohepatitis (NASH) Treatment Market, By Distribution Channel
      - Hospital Pharmacies
      - Retail and Specialty Pharmacies
      - Other Pharmacies
  - Saudi Arabia
    - Saudi Arabia Non-Alcoholic Steatohepatitis (NASH) Treatment Market, By Drug
      - Vitamin E and Pioglitazone
      - Obeticholic Acid (OCA)
      - Lanifibranor
      - Semaglutide
      - Resmetirom
      - Aramchol
      - Cenicriviroc
      - Other Drugs
      - Total
    - Saudi Arabia Non-Alcoholic Steatohepatitis (NASH) Treatment Market, By Disease Stage
      - NASH Stage F0
      - NASH Stage F1
      - NASH Stage F2
      - NASH Stage F3
      - NASH Stage F4
    - Saudi Arabia Non-Alcoholic Steatohepatitis (NASH) Treatment Market, By Distribution Channel
      - Hospital Pharmacies
      - Retail and Specialty Pharmacies
      - Other Pharmacies
  - Kuwait
    - Kuwait Non-Alcoholic Steatohepatitis (NASH) Treatment Market, By Drug
      - Vitamin E and Pioglitazone
      - Obeticholic Acid (OCA)
      - Lanifibranor
      - Semaglutide
      - Resmetirom
      - Aramchol
      - Cenicriviroc
      - Other Drugs
      - Total
    - Kuwait Non-Alcoholic Steatohepatitis (NASH) Treatment Market, By Disease Stage
      - NASH Stage F0
      - NASH Stage F1
      - NASH Stage F2
      - NASH Stage F3
      - NASH Stage F4
    - Kuwait Non-Alcoholic Steatohepatitis (NASH) Treatment Market, By Distribution Channel
      - Hospital Pharmacies
      - Retail and Specialty Pharmacies
      - Other Pharmacies
  - UAE
    - UAE Non-Alcoholic Steatohepatitis (NASH) Treatment Market, By Drug
      - Vitamin E and Pioglitazone
      - Obeticholic Acid (OCA)
      - Lanifibranor
      - Semaglutide
      - Resmetirom
      - Aramchol
      - Cenicriviroc
      - Other Drugs
      - Total
    - UAE Non-Alcoholic Steatohepatitis (NASH) Treatment Market, By Disease Stage
      - NASH Stage F0
      - NASH Stage F1
      - NASH Stage F2
      - NASH Stage F3
      - NASH Stage F4
    - UAE Non-Alcoholic Steatohepatitis (NASH) Treatment Market, By Distribution Channel
      - Hospital Pharmacies
      - Retail and Specialty Pharmacies
      - Other Pharmacies

Report content

Qualitative Analysis

Industry overview
Industry trends
Market drivers and restraints
Market size
Growth prospects
Porter’s analysis
PESTEL analysis
Key market opportunities prioritized
Competitive landscape
- Company overview
- Financial performance
- Product benchmarking
- Latest strategic developments

Quantitative Analysis

Market size, estimates, and forecast from 2018 to 2030
Market estimates and forecast for product segments up to 2030
Regional market size and forecast for product segments up to 2030
Market estimates and forecast for application segments up to 2030
Regional market size and forecast for application segments up to 2030
Company financial performance

GET A FREE SAMPLE

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

Or view our licence options:

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

ESOMAR certified & member

ISO Certified

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.